Article

My Commemoration

Author(s):

Today is a special day for me, a commemoration (I love that word) of sorts; it marks a third of a century that I've been in practice.

Today is a special day for me, a commemoration (I love that word) of sorts; it marks a third of a century that I’ve been in practice. I still remember my first day. It was Friday, December 3, 1976. I had just joined a four-man general practice group after one of the doctors had recently left with renal failure. And that weekend I was to take my first call for the group. My first patient was an 80-something-year-old guy who was still working for a local newspaper, folding papers every morning for delivery.

He came in complaining of his heart “just flopping around,” but no chest pain or shortness of breath. I took his pulse and it was bouncing all over the place. I asked what medication he was taking and he said, “a little white pill.” But he hadn’t seen a doctor in a very long time, and claimed to have been taking the pill for 25 years. I didn’t get an EKG, nor digoxin level, but gathered my recently attained medical education into one corner of my brain, and determined that he was most likely a bit dig toxic. Don’t forget, back then there were a lot fewer little white pills than there are now.

I told him to stop his medication and come back Monday morning for a recheck. He did and his heart rate was regular and he was feeling fine. I thought this job was going to be a snap. Then over the years along came HMOs, PPOs, ICDs, CPTs, CTs, MRIs, BC/BS, UHC, HIPAA, and EHRs. Then things got even worse; estrogens were found to be bad for you and chocolate good... well, maybe that’s not so bad!

Related Videos
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Highlighting the Danger of SCI Progression during iTTP Remission, with Shruti Chaturvedi, MBSS, MS
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
© 2024 MJH Life Sciences

All rights reserved.